Summary
In this chapter we present a method based on the (α,β)-k-feature set problem for identifying relevant attributes in high-dimensional datasets for classification purposes. We present a case-study of biomedical interest. Using the gene expression of thousands of genes, we show that the method can give a reduced set that can identify samples as belonging to prostate cancer tumors or not. We thus address the need of finding novel methods that can deal with classification problems that involve feature selection from several thousand features, while we only have on the order of one hundred samples. The methodology appears to be very robust in this prostate cancer case study. It has lead to the identification of a set of differentially expressed genes that are highly predictive of the cells transition to a more malignant type, thus departing from the profile which is characteristic of its originating tissue. Although the method is presented with a particular bioinformatics application in mind, it can clearly be used in other domains. A biological analysis illustrates on the relevance of the genes found, and links to the most current developments in prostate cancer biomarker studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Saeys, Y., Inza, I., Larranaga, P.: A review of feature selection techniques in bioinformatics. Bioinformatics 23(19), 2507–2517 (2007)
B. D. W. Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69(3), 89–95 (2001)
The prostate cancer foundation of australia (08/08/2008 2007)
Cotta, C., Sloper, C., Moscato, P.: Evolutionary search of thresholds for robust feature set selection: application to the analysis of microarray data. In: Raidl, G.R., Cagnoni, S., Branke, J., Corne, D.W., Drechsler, R., Jin, Y., Johnson, C.G., Machado, P., Marchiori, E., Rothlauf, F., Smith, G.D., Squillero, G. (eds.) EvoWorkshops 2004. LNCS, vol. 3005, pp. 21–30. Springer, Heidelberg (2004)
Cotta, C., Moscato, P.: The k-Feature Set problem is W[2]-complete. Journal of Computer and System Sciences 67(4), 686–690 (2003)
Davies, S., Russell, S.: NP-completeness of searches for smallest possible feature sets. In: Proceedings of the AAAI Symposium on Relevance, pp. 41–43 (1994)
Downey, R., Fellows, M.: Parameterized Complexity. Mongraphs in Computer Science. Springer, Heidelberg (1999)
Berretta, R., Mendes, A., Moscato, P.: Selection of discriminative genes in microarray experiments using mathematical programming. Journal of Research and Practice in Information Technology 39(4), 231–243 (2007)
Moscato, P., Mathieson, L., Mendes, A., Berretta, R.: The electronic primaries: Predicting the u.s. presidency using feature selection with safe data reduction. In: Estivill-Castro, V. (ed.) Twenty-Eighth Australasian Computer Science Conference (ACSC 2005). CRPIT, vol. 38, pp. 371–380. ACS, Newcastle (2005)
Berretta, R., Mendes, A., Moscato, P.: Integer programming models and algorithms for molecular classification of cancer from microarray data. In: Estivill-Castro, V. (ed.) Twenty-Eighth Australasian Computer Science Conference (ACSC 2005). CRPIT, vol. 38, pp. 361–370. ACS, Newcastle (2005)
Moscato, P., Berretta, R., Hourani, M., Mendes, A., Cotta, C.: Genes related with Alzheimer’s disease: A comparison of evolutionary search, statistical and integer programming approaches. In: Rothlauf, F., Branke, J., Cagnoni, S., Corne, D.W., Drechsler, R., Jin, Y., Machado, P., Marchiori, E., Romero, J., Smith, G.D., Squillero, G. (eds.) EvoWorkshops 2005. LNCS, vol. 3449, pp. 84–94. Springer, Heidelberg (2005)
Fayyad, U.M., Irani, K.B.: Multi-interval discretization of continuous-valued attributes for classification learning. In: IJCAI, pp. 1022–1029 (1993)
Berretta, R., Costa, W., Moscato, P.: Combinatorial optimization models for finding genetic signatures from gene expression datasets. In: Keith, J.M. (ed.) Bioinformatics, Volume II: Structure, Function and Applications, Methods in Molecura Biology, ch. 19, pp. 363–378. Humana Press (2008)
Hourani, M., Mendes, A., Berretta, R., Moscato, P.: Genetic biomarkers for brain hemisphere differentiation in parkinson’s disease. In: AIP Conference Proceedings, vol. 952(1), pp. 207–216 (2007)
Hourani, M., Berretta, R., Mendes, A., Moscato, P.: Genetic signatures for a rodent model of parkinson’s disease using combinatorial optimization methods. In: Keith, J.M. (ed.) Bioinformatics, Volume II: Structure, Function and Applications. Structure, Function and Applications, Methods in Molecura Biology, vol. II, pp. 379–392. Humana Press (2008), doi:10.1007/978-1-60327-429-6_20
Ravetti, M.G., Moscato, P.: Identification of a 5-protein biomarker molecular signature for predicting alzheimer’s disease, PLOS One (accepted)
Ross, D., Scherf, U., Eisen, M., et al.: Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics 24(3), 227–235 (2000)
Brown, V., Ossadtchi, A., Khan, A., Cherry, S., Leahy, R., Smith, D.: High-throughput imaging of brain gene expression. Genome Research 12(2), 244–254 (2002)
Singh, D., Febbo, P.G., Ross, K., Jackson, D.G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A.A., D’Amico, A.V., Richie, J.P., Lander, E.S., Loda, M., Kantoff, P.W., Golub, T.R., Sellers, W.R.: Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1(2), 203–209 (2002)
Orsenigo, C.: Gene selection and cancer microarray data classification via mixed-integer optimization. In: Marchiori, E., Moore, J.H. (eds.) EvoBIO 2008. LNCS, vol. 4973, pp. 141–152. Springer, Heidelberg (2008)
Shah, S., Kusiak, A.: Cancer gene search with data-mining and genetic algorithms. Computers in Biology and Medicine 37(2), 251–261 (2007)
Wang, H.-Q., Wong, H.-S., Huang, D.-S., Shu, J.: Extracting gene regulation information for cancer classification. Pattern Recognition 40(12), 3379–3392 (2007)
Chandran, U.R., Ma, C., Dhir, R., Bisceglia, M., Lyons-Weiler, M., Liangand, W., Michalopoulos, G., Becich, M., Monzon, F.A.: Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 7(64)
Yu, Y.P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., Michalopoulos, G., Becich, M., Luo, J.-H.: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22(14), 2790–2799 (2004)
Tibshirani, R., Hastie, T., Narasimhan, B., Chu, G.: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proceedings of the National Academy of Sciences of the United States of America 99(10), 6567–6572 (2002)
Tusher, V.G., Tibshirani, R., Chu, G.: Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 98(9), 5116–5121 (2001)
Gomez Ravetti, M., Moscato, P.: Identification of a 5-protein biomarker molecular signature for predicting alzheimer’s disease. PLOS One 3(9), e3111 (2008)
Tibshirani, R., Hastie, T., Narasimhan, B., Chu, G.: Class prediction by nearest shrunken centroids, with applications to dna microarrays. Statistical Science 18(1), 104–117 (2003)
Banerjee, A.G., Bhattacharyya, I., Vishwanatha, J.K.: Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Mol. Cancer Ther. 4(6), 865–875 (2005)
Eichele, K., Ramer, R., Hinz, B.: Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin d synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells. Oncogene 27(21), 3032–3044 (2008)
Su, B., Guan, M., Xia, J., Lu, Y.: Stimulation of lipocalin-type prostaglandin d synthase by retinoic acid coincides with inhibition of cell proliferation in human 3ao ovarian cancer cells. Cell Biol. Int. 27(7), 587–592 (2003)
Kim, J., Yang, P., Suraokar, M., Sabichi, A., Llansa, N., Mendoza, G., Subbarayan, V., Logothetis, C., Newman, R., Lippman, S., Menter, D.: Suppression of prostate tumor cell growth by stromal cell prostaglandin d synthase-derived products. Cancer Res. 65(14), 6189–6198 (2005)
Park, J.M., Kanaoka, Y., Eguchi, N., Aritake, K., Grujic, S., Materi, A.M., Buslon, V.S., Tippin, B.L., Kwong, A.M., Salido, E., French, S.W., Urade, Y., Lin, H.J.: Hematopoietic prostaglandin d synthase suppresses intestinal adenomas in apcmin/+ mice. Cancer Res. 67(3), 881–889 (2007)
Richard, C.L., Lowthers, E.L., Blay, J.: 15-deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. Exp. Cell Res. 313(16), 3446–3458 (2007)
Chen, Y., Perussia, B., Campbell, K.: Prostaglandin d2 suppresses human nk cell function via signaling through d prostanoid receptor. J. Immunol. 179(5), 2766–2773 (2007)
Cao, H., Xiao, L., Park, G., Wang, X., Azim, A.C., Christman, J.W., van Breemen, R.B.: An improved lc-ms/ms method for the quantification of prostaglandins e(2) and d(2) production in biological fluids. Anal. Biochem. 372(1), 41–51 (2008)
Torres, D., Paget, C., Fontaine, J., Mallevaey, T., Matsuoka, T., Narumiya, T.M.S., Capron, M., Gosset, P., Faveeuw, C., Trottein, F.: Prostaglandin d2 inhibits the production of ifn-gamma by invariant nk t cells: consequences in the control of b16 melanoma. J. Immunol. 180(2), 783–792 (2008)
Watson, M., Lind, M., Smith, L., Drew, P., Cawkwell, L.: Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model. Acta Oncol. 46(5), 651–658 (2007)
Guy, C.A., Hoogendoorn, B., Smith, S.K., Coleman, S., O’Donovan, M.C., Buckland, P.R.: Promoter polymorphisms in glutathione-s-transferase genes affect transcription. Pharmacogenetics 14(1), 45–51 (2004)
Denson, J., Xi, Z., Wu, Y., Yang, W., Neale, G., Zhang, J.: Screening for inter-individual splicing differences in human gstm4 and the discovery of a single nucleotide substitution related to the tandem skipping of two exons. Gene. 379, 14855 (2006)
Efferth, T., Volm, M.: Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate. Vivo 19(1), 225–232 (2005)
Knight, T., Choudhuri, S., Klaassen, C.: Constitutive mrna expression of various glutathione s-transferase isoforms in different tissues of mice. Toxicol Sci. 100(2), 513–524 (2007)
Liloglou, T., Walters, M., Maloney, P., Youngson, J., Field, J.K.: A t2517c polymorphism in the gstm4 gene is associated with risk of developing lung cancer. Lung Cancer 7(2), 143–146 (2002)
DiLella, A.G., Toner, T.J., Austin, C.P., Connolly, B.M.: Identification of genes differentially expressed in benign prostatic hyperplasia. J. Histochem Cytochem. 49(5), 669–670 (2001)
Luo, J., Dunn, T.A., Ewing, C.M., Walsh, P.C., Isaacs, W.B.: Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma. Prostate 57(2), 134–139 (2003)
Grigo, K., Wirsing, A., Lucas, B., Klein-Hitpass, L., Ryffel, G.U.: Hnf4 alpha orchestrates a set of 14 genes to down-regulate cell proliferation in kidney cells. Biol. Chem. 389(2), 179–187 (2008)
Wu, Q., Parry, G.: Hepsin and prostate cancer. Front Biosci. 12, 5052–5059 (2007)
Matsuo, T., Nakamura, K., Takamoto, N., Kodama, J., Hongo, A., Abrzua, F., Nasu, Y., Kumon, H., Hiramatsu, Y.: Expression of the serine protease hepsin and clinical outcome of human endometrial cancer. Anticancer Res. 28(1A), 159–164 (2008)
Kelly, K.A., Setlur, S.R., Ross, R., Anbazhagan, R., Waterman, P., Rubin, M.A., Weissleder, R.: Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res. 68(7), 2286–2291 (2008)
Magee, J.A., Araki, T., Patil, S., Ehrig, T., True, L., Humphrey, P.A., Catalona, W.J., Watson, M.A., Milbrandt, J.: Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 61(15), 5692–5696 (2001)
Huppi, K., Chandramouli, G.V.: Molecular profiling of prostate cancer. Curr. Urol. Rep. 5(1), 45–51 (2004)
Xu, L., Tan, A.C., Naiman, D.Q., Geman, D., Winslow, R.L.: Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data. Bioinformatics 21(20), 3905–3911 (2005)
Riddick, A.C., Barker, C., Sheriffs, I., Bass, R., Ellis, V., Sethia, K.K., Edwards, D.R., Ball, R.Y.: Banking of fresh-frozen prostate tissue: methods, validation and use. BJU Int. 91(4), 315–324 (2003)
Stephan, C., Yousef, G.M., Scorilas, A., Jung, K., Jung, M., Kristiansen, G., Hauptmann, S., Kishi, T., Nakamura, T., Loening, S.A., Diamandis, E.P.: Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. J. Urol. 171(1), 187–191 (2004)
Fromont, G., Chene, L., Vidaud, M., Vallancien, G., Mangin, P., Fournier, G., Validire, P., Latil, A., Cussenot, O.: Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman real-time rt-pcr. Int. J. Cancer. 114(2), 174–181 (2005)
Pal, P., Xi, H., Kaushal, R., Sun, G., Jin, C.H., Jin, L., Suarez, B.K., Catalona, W.J., Deka, R.: Variants in the HEPSIN gene are associated with prostate cancer in men of european origin. Hum. Genet. 120(2), 187–192 (2006)
Burmester, J.K., Suarez, B.K., Lin, J.H., Jin, C.H., Miller, R.D., Zhang, K.Q., Salzman, S.A., Reding, D.J., Catalona, W.J.: Analysis of candidate genes for prostate cancer. Hum Hered. 57(4), 172–178 (2004)
Heinrich, R., Ben-Izhak, E.L.O., Aronheim, A.: The c-Jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene. J. Biol. Chem. 279(7), 5708–5715 (2004)
Mehraein-Ghomi, F., Lee, E., Church, D.R., Thompson, T.A., Basu, H.S., Wilding, G.: Jund mediates androgen-induced oxidative stress in androgen dependent lncap human prostate cancer cells. Prostate 68(9), 924–934 (2008)
Polytarchou, C., Hatziapostolou, M., Papadimitriou, E.: Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J. Biol. Chem. 280(49), 40428–40435 (2005)
Zhang, J.S., Gong, A., Cheville, J.C., Smith, D.I., Young, C.Y.: Agr2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer. 43(3), 249–259 (2005)
Zhang, Y., Forootan, S.S., Liu, D., Barraclough, R., Foster, C.S., Rudland, P.S., Ke, Y.: Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis. 10(3), 293–300 (2007)
LI, L.I.K., Shishkin, S.S., Khasigov, P.Z., Dzeranov, N.K., Kazachenko, A.V., Toropygin, I., Mamykina, S.V.: Identification of agr2 protein, a novel potential cancer marker, using proteomics technologies, [article in russian]. Prikl Biokhim Mikrobiol. 42(4), 480–484 (2006)
Wang, Z., Hao, Y., Lowe, A.W.: The adenocarcinoma-associated antigen, agr2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res. 68(2), 492–497 (2008)
Kristiansen, G., Pilarsky, C., Wissmann, C., Kaiser, S., Bruemmendorf, T., Roepcke, S., Dahl, E., Hinzmann, B., Specht, T., Pervan, J., Stephan, C., Loening, S., Dietel, M., Rosenthal, A.: Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J. Pathol. 205(3), 359–376 (2005)
Landers, K.A., Samaratunga, H., Teng, L., Buck, M., Burger, M.J., Scells, B., Lavin, M.F., Gardiner, R.A.: Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. Br. J. Cancer 99(3), 491–501 (2008)
Kim, S.O., Lee, I.J., Choi, Y.H.: Genistein reduced the invasive activity of human breast carcinoma cells as a result of decreased tight junction permeability and modulation of tight junction proteins. Cancer Lett. (Epub ahead of print)
Hough, C.D., Sherman-Baust, C.A., Pizer, E.S., Montz, F.J., Im, D.D., Rosenshein, N.B., Cho, K.R., Riggins, G.J., Morin, P.J.: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 60(22), 6281–6287 (2000)
Kleinberg, L., Holth, A., Trope, C.G., Reich, R., Davidson, B.: Claudin upregulation in ovarian carcinoma effusions is associated with poor survival. Hum Pathol. 39(5), 747–757 (2008)
Long, H., Crean, C.D., Lee, W.H., Cummings, O.W., Gabig, T.G.: Expression of clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res. 61(21), 7878–7881 (2001)
Morin, P.J.: Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 65(21), 9603–9606 (2005)
Hewitt, K.J., Agarwal, R., Morin, P.J.: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6, 186 (2006)
Nichols, L.S., Ashfaq, R., Iacobuzio-Donahue, C.A.: Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J. Clin. Pathol. 121(2), 226–230 (2004)
Foss, C.A., Fox, J.J., Feldmann, G., Maitra, A., Iacobuzio-Donohue, C., Kern, S.E., Hruban, R., Pomper, M.G.: Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer. Mol. Imaging. 6(2), 131–139 (2007)
Hanada, S., Maeshima, A., Matsuno, Y., Ohta, T., Ohki, M., Yoshida, T., Hayashi, Y., Yoshizawa, Y., Hirohashi, S., Sakamoto, M.: Expression profile of early lung adenocarcinoma: identification of mrp3 as a molecular marker for early progression. J. Pathol. 216(1), 75–82 (2008)
Nishino, R., Honda, M., Yamashita, T., Takatori, H., Minato, H., Zen, Y., Sasaki, M., Takamura, H., Horimoto, K., Ohta, T., Nakanuma, Y., Kaneko, S.: Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J. Hepatol. 49(2), 207–216 (2008)
Bello, I.O., Vilen, S.T., Niinimaa, A., Kantola, S., Soini, Y., Salo, T.: Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum. Pathol. 39(8), 1212–1220 (2008)
Ashton-Chess, J., Giral, M., Mengel, M., Renaudin, K., Foucher, Y., Gwinner, W., Braud, C., Dugast, E., Quillard, T., Thebault, P., Chiffoleau, E., Braudeau, C., Charreau, B., Soulillou, J., Brouard, S.: Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J. Am. Soc. Nephrol. 19(6), 1116–1127 (2008), http://jasn.asnjournals.org/cgi/content/abstract/19/6/1116
Röthlisberger, B., Heizmann, M., Bargetzi, M.J., Huber, A.R.: Trib1 overexpression in acute myeloid leukemia. Cancer Genet Cytogenet. 176(1), 58–60 (2007)
Rücker, F.G., Bullinger, L., Schwaenen, C., Lipka, D.B., Wessendorf, S., Fröhling, S., Bentz, M., Miller, S., Scholl, C., Schlenk, R.F., Radlwimmer, B., Kestler, H.A., Pollack, J.R., Lichter, P., Döhner, K., Döhner, H.: Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J. Clin. Oncol. 25(9), 1151–1152 (2007)
Keeshan, K., Shestova, O., Ussin, L., Pear, W.S.: Tribbles homolog 2 (trib2) and hoxa9 cooperate to accelerate acute myelogenous leukemia. Blood Cells Mol. Dis. 40(1), 119–121 (2008)
Puskas, L.G., Juhasz, F., Zarva, A., Hackler Jr., L., Farid, N.R.: Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. Cell Mol. Biol. 51(2), 177–186 (2005)
Puiffe, M.L., Page, C.L., Filali-Mouhim, A., Zietarska, M., Ouellet, V., Tonin, P.N., Chevrette, M., Provencher, D.M., Mes-Masson, A.M.: Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia 9(10), 820–829 (2007)
Mangs, A.H., Morris, B.J.: ZRANB2: Structural and functional insights into a novel splicing protein. Int. J. Biochem. Cell Biol. 40(11), 2353–2357 (2008)
Leiblich, A., Cross, S.S., Catto, J.W., Phillips, J.T., Leung, H.Y., Hamdy, F.C., Rehman, I.: Lactate dehydrogenase-b is silenced by promoter hypermethylation in human prostate cancer. Oncogene 25(20), 2953–2960 (2006)
Glen, A., Gan, C.S., Hamdy, F.C., Eaton, C.L., Cross, S.S., Catto, J.W., Wright, P.C., Rehman, I.: Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression. J. Proteome Res. 7(3), 897–907 (2008)
Wingender, E.: The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform. 9(4), 326–332 (2008)
Kataoka, K., Noda, M., Nishizawa, M.: Maf nuclear oncoprotein recognizes sequences related to an ap-1 site and forms heterodimers with both fos and jun. Mol. Cell. Biol. 14(1), 700–712 (1994)
Hofer, M., Fecko, A., Shen, R., Setlur, S., Pienta, K., Tomlins, S., Chinnaiyan, A., Rubin, M.: Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors. Neoplasia 6(5), 503–512 (2004)
Toffolatti, L., Gastaldo, L.R., Patarnello, T., Romualdi, C., Merlanti, R., Montesissa, C., Poppi, L., Castagnaro, M., Bargelloni, L.: Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones. Domest. Anim. Endocrinol. 30(1), 38–55 (2006)
So, A., Gleave, M., Hurtado-Col, A., Nelson, C.: Mechanisms of the development of androgen independence in prostate cancer. World J. Urol. 23(1), 1–9 (2005)
Lapointe, J., Li, C., Higgins, J., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., Ekman, P., DeMarzo, A., Tibshirani, R., Botstein, D., Brown, P., Brooks, J., Pollack, J.: Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl. Acad. Sci. USA 101(3), 811–816 (2004)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ravetti, M.G., Berretta, R., Moscato, P. (2009). Novel Biomarkers for Prostate Cancer Revealed by (α,β)-k-Feature Sets. In: Abraham, A., Hassanien, AE., Snášel, V. (eds) Foundations of Computational Intelligence Volume 5. Studies in Computational Intelligence, vol 205. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01536-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-01536-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01535-9
Online ISBN: 978-3-642-01536-6
eBook Packages: EngineeringEngineering (R0)